Trial intelligence / Profile preview

Oral contraceptives versus GnRH agonist pretreatment before IVF/ICSI in severe endometriosis

NL-OMON55530Recruiting

Sponsor
Vrije University Medical Center
Start
Oct 2018
Countries
1
01

Overview

Randomised, open-label trial in endometriosis (2 arms), sponsored by Vrije University Medical Center. Primary endpoint: Live birth rate after fresh embryo transfer. Started Oct 2018; status: recruiting.

02

Conditions

endometriosis

Beyond the preview

Go deeper on NL-OMON55530.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON55530.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call